{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06273111",
            "orgStudyIdInfo": {
                "id": "73840"
            },
            "organization": {
                "fullName": "Stanford University",
                "class": "OTHER"
            },
            "briefTitle": "Topical Simvastatin for Treating Infantile Hemangioma",
            "officialTitle": "A Pilot Study Using Topical Statins to Treat Children With Infantile Hemangioma",
            "acronym": "TSTIH",
            "therapeuticArea": [
                "Dermatology"
            ],
            "study": "topical-simvastatin-for-treating-infantile-hemangioma"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-02",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-04-01",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-07-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-12-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2024-02-15",
            "studyFirstSubmitQcDate": "2024-02-15",
            "studyFirstPostDateStruct": {
                "date": "2024-02-22",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-02-15",
            "lastUpdatePostDateStruct": {
                "date": "2024-02-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Joyce Teng",
                "investigatorTitle": "Professor of Dermatology and Pediatric",
                "investigatorAffiliation": "Stanford University"
            },
            "leadSponsor": {
                "name": "Joyce Teng",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "Stanford University",
                    "class": "OTHER"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a 24-week, open-label pilot study to evaluate the safety and preliminary efficacy of 5% simvastatin ointment in treating 12 children with superficial IH.\n\nThe primary objective:\n\nTo evaluate the safety and tolerability of topical treatment with 5% simvastatin ointment for superficial IH over 24 weeks.\n\nThe secondary objective:\n\n1.1 To evaluate the efficacy of 5% simvastatin ointment when topical treatment is administered twice daily for 24 weeks. Evaluation is performed at each clinic visit via investigator global assessment (IGA) based on standardized 3D digital photography and hemangioma activity score (HAS).\n\n1.2 To evaluate the impact of 5% simvastatin ointment on quality of life using the IH-QoL questionnaire."
        },
        "conditionsModule": {
            "conditions": [
                "Hemangioma Skin"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "EARLY_PHASE1"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 12,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "5% simvastatin ointment",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will be applied 5% simvastatin ointment on IH lesion",
                    "interventionNames": [
                        "Drug: 5% simvastatin ointment"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "5% simvastatin ointment",
                    "description": "5% simvastatin ointment will be applied directly on IH lesion twice per day for 24 weeks",
                    "armGroupLabels": [
                        "5% simvastatin ointment"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Number of Participants with Treatment-Related Adverse Events",
                    "timeFrame": "Baseline through week 24"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percentage of participants achieved a 50% HAS reduction at week 12 compared to baseline",
                    "timeFrame": "Baseline through week 12"
                },
                {
                    "measure": "Percentage of participants achieved a 75% HAS reduction from baseline by the end of the study (week 24) compared to baseline.",
                    "timeFrame": "Baseline through week 24"
                },
                {
                    "measure": "Percentage of targeted hemangiomas with complete or nearly complete resolution (IGA 0 or 1), defined as a minimal degree of telangiectasia, skin thickening, and no definitive palpable cutaneous texture changes.",
                    "timeFrame": "Baseline through week 24"
                },
                {
                    "measure": "Percentage of targeted hemangiomas that are stabilized (no noticeable change to baseline) or continue to progress.",
                    "timeFrame": "Baseline through week 24"
                },
                {
                    "measure": "Percentage of participants with a significant improvement in quality-of-life, defined as > 50% reduction in the IH-QoL questionnaire score from baseline to week 24.",
                    "timeFrame": "Baseline through week 24"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Healthy children aged between 3 months and 5 years.\n* Newly diagnosed superficial IH or experiencing rebound growth with a superficial component.\n* Participants must possess at least one IH lesion with the longest diameter equal to or greater than 2 cm, located on any part of the body except the lips.\n* Participants must not have received any of the following treatments for their IH:\n\n  * Topical medical therapy within the past 2 weeks.\n  * Systemic medical therapy within the past 3 months.\n  * Laser treatment within the past 6 weeks.\n* Written informed consent from the parent(s)/guardian(s) of minor participants must be obtained before any study procedure is performed.\n\nExclusion Criteria:\n\n* IH is primarily characterized as subcutaneous, and deep, with minimal cutaneous involvement for evaluation.\n* IH with active ulceration.\n* IH to be treated involving the lips mainly.\n* Participants with concurrent skin conditions that may impede accurate clinical assessment of the IH.\n* Participants with hereditary or metabolic disorders requiring systemic statin therapy.\n* Participants who are allergic to statins, or other ingredients present in the topical medication.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "3 Months",
            "maximumAge": "5 Years",
            "stdAges": [
                "CHILD"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Joyce Teng, MD, PhD",
                    "role": "CONTACT",
                    "phone": "650-724-9627",
                    "email": "jteng3@stanford.edu"
                },
                {
                    "name": "Ramrada Lekwuttikarn, MD",
                    "role": "CONTACT",
                    "phone": "650-313-8207",
                    "email": "ramrada1@stanford.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Joyce Teng, MD, PhD",
                    "affiliation": "Stanford University",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "Stanford University",
                    "city": "Palo Alto",
                    "state": "California",
                    "zip": "94304",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Ramrada Lekwuttikarn, MD",
                            "role": "CONTACT",
                            "phone": "650-313-8207",
                            "email": "ramrada1@stanford.edu"
                        },
                        {
                            "name": "Thomas Buschbacher",
                            "role": "CONTACT",
                            "phone": "352-278-7603",
                            "email": "tbusch@stanford.edu"
                        }
                    ],
                    "geoPoint": {
                        "lat": 37.44188,
                        "lon": -122.14302
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000006391",
                    "term": "Hemangioma"
                },
                {
                    "id": "D000018324",
                    "term": "Hemangioma, Capillary"
                },
                {
                    "id": "D000019339",
                    "term": "Port-Wine Stain"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009383",
                    "term": "Neoplasms, Vascular Tissue"
                },
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000012868",
                    "term": "Skin Abnormalities"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                },
                {
                    "id": "D000012871",
                    "term": "Skin Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9479",
                    "name": "Hemangioma",
                    "asFound": "Hemangioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M20468",
                    "name": "Hemangioma, Capillary",
                    "asFound": "Infantile Hemangioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21316",
                    "name": "Port-Wine Stain",
                    "asFound": "Infantile Hemangioma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12328",
                    "name": "Neoplasms, Vascular Tissue",
                    "relevance": "LOW"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M15672",
                    "name": "Skin Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M15674",
                    "name": "Skin Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000019821",
                    "term": "Simvastatin"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000924",
                    "term": "Anticholesteremic Agents"
                },
                {
                    "id": "D000000960",
                    "term": "Hypolipidemic Agents"
                },
                {
                    "id": "D000000963",
                    "term": "Antimetabolites"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000057847",
                    "term": "Lipid Regulating Agents"
                },
                {
                    "id": "D000019161",
                    "term": "Hydroxymethylglutaryl-CoA Reductase Inhibitors"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21713",
                    "name": "Simvastatin",
                    "asFound": "Parameters",
                    "relevance": "HIGH"
                },
                {
                    "id": "M21155",
                    "name": "Hydroxymethylglutaryl-CoA Reductase Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4243",
                    "name": "Anticholesteremic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4278",
                    "name": "Hypolipidemic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4281",
                    "name": "Antimetabolites",
                    "relevance": "LOW"
                },
                {
                    "id": "M28883",
                    "name": "Lipid Regulating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Lipd",
                    "name": "Lipid Regulating Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}